Inhibikase Therapeutics (IKT) Insider Trading & Ownership → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free IKT Stock Alerts $1.31 -0.05 (-3.68%) (As of 05/10/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Inhibikase Therapeutics (NYSE:IKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.30%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$63,885.18Number OfInsiders Selling(Last 3 Years)0 Get IKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Inhibikase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IKT Insider Buying and Selling by Quarter Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Inhibikase Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2022Milton H WernerCEOBuy833$4.80$3,998.40 5/27/2022Milton H WernerCEOBuy833$5.88$4,898.04 5/20/2022Milton H WernerCEOBuy1,666$3.60$5,997.60 5/19/2022Joseph FrattaroliCFOBuy658$3.84$2,526.72 11/17/2021Milton H WernerCEOBuy3,931$11.82$46,464.42 (Data available from 1/1/2013 forward) IKT Insider Trading Activity - Frequently Asked Questions Who is on Inhibikase Therapeutics's Insider Roster? The list of insiders at Inhibikase Therapeutics includes Joseph Frattaroli, and Milton H Werner. Learn more on insiders at IKT. What percentage of Inhibikase Therapeutics stock is owned by insiders? 20.30% of Inhibikase Therapeutics stock is owned by insiders. Learn more on IKT's insider holdings. Which Inhibikase Therapeutics insiders have been buying company stock? The following insiders have purchased IKT shares in the last 24 months: Joseph Frattaroli ($2,526.72), and Milton H Werner ($14,894.04). How much insider buying is happening at Inhibikase Therapeutics? Insiders have purchased a total of 3,990 IKT shares in the last 24 months for a total of $17,420.76 bought. More Insider Trading Tools from MarketBeat Related Companies: SRNE Insider Selling ONVO Insider Selling PALI Insider Selling CELZ Insider Selling TTNP Insider Selling BCDA Insider Selling FRTX Insider Selling TCON Insider Selling FNCH Insider Selling KRBP Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NYSE:IKT) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithObama’s Forever Term [exposed]Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityDems have chosen Biden replacement?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
